Published in Cancer Weekly, September 5th, 2006
"The aim of our study is to investigate the mechanism of metastasis, to detect novel metastasis-associated molecules, and to evaluate the molecules from the point of view of clinical application. A monoclonal antibody MH8-11, which we established, recognizes a glycoprotein that is identical to APN/CD13," scientists in Japan report.
T. Tokuhara and colleagues, Kitano Hospital, wrote, "APN/CD13 degrades the extracellular matrix, while it is also involved in cell motility and improves angiogenesis. We investigated the expression of APN/CD13 in 194 cases of NSCLC by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.